Phospholipid scramblase 1 is involved in immunogenic cell death and contributes to dendritic cell-based vaccine efficiency to elicit antitumor immune response in vitro
- Author(s)
- Montico, B; Nigro, A; Lamberti, MJ; Martorelli, D; Mastorci, K; Ravo, M; Giurato, G; Steffan, A; Dolcetti, R; Casolaro, V; Dal Col, J;
- Details
- Publication Year 2024-02,Volume 26,Issue #2,Page 145-156
- Journal Title
- Cytotherapy
- Publication Type
- Research article
- Abstract
- BACKGROUND AIMS: Whole tumor cell lysates (TCLs) obtained from cancer cells previously killed by treatments able to promote immunogenic cell death (ICD) can be efficiently used as a source of tumor-associated antigens for the development of highly efficient dendritic cell (DC)-based vaccines. Herein, the potential role of the interferon (IFN)-inducible protein phospholipid scramblase 1 (PLSCR1) in influencing immunogenic features of dying cancer cells and in enhancing DC-based vaccine efficiency was investigated. METHODS: PLSCR1 expression was evaluated in different mantle-cell lymphoma (MCL) cell lines following ICD induction by 9-cis-retinoic acid (RA)/IFN-α combination, and commercial kinase inhibitor was used to identify the signaling pathway involved in its upregulation. A Mino cell line ectopically expressing PLSCR1 was generated to investigate the potential involvement of this protein in modulating ICD features. Whole TCLs obtained from Mino overexpressing PLSCR1 were used for DC loading, and loaded DCs were employed for generation of tumor antigen-specific cytotoxic T lymphocytes. RESULTS: The ICD inducer RA/IFN-α combination promoted PLSCR1 expression through STAT1 activation. PLSCR1 upregulation favored pro-apoptotic effects of RA/IFN-α treatment and enhanced the exposure of calreticulin on cell surface. Moreover, DCs loaded with TCLs obtained from Mino ectopically expressing PLSCR1 elicited in vitro greater T-cell-mediated antitumor responses compared with DCs loaded with TCLs derived from Mino infected with empty vector or the parental cell line. Conversely, PLSCR1 knock-down inhibited the stimulating activity of DCs loaded with RA/IFN-α-treated TCLs to elicit cyclin D1 peptide-specific cytotoxic T lymphocytes. CONCLUSIONS: Our results indicate that PLSCR1 improved ICD-associated calreticulin exposure induced by RA/IFN-α and was clearly involved in DC-based vaccine efficiency as well, suggesting a potential contribution in the control of pathways associated to DC activation, possibly including those involved in antigen uptake and concomitant antitumor immune response activation.
- Publisher
- Wiley
- Keywords
- Phospholipid Transfer Proteins/genetics/metabolism; Calreticulin/metabolism; Immunogenic Cell Death; *Antineoplastic Agents/metabolism; Antigens, Neoplasm; Immunity; Dendritic Cells; *Vaccines/metabolism; DC-based vaccine; mantle cell lymphoma; phospholipid scramblase 1
- Department(s)
- Laboratory Research
- Publisher's Version
- https://doi.org/10.1016/j.jcyt.2023.11.014
- Open Access at Publisher's Site
https://doi.org/10.1016/j.jcyt.2023.11.014- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-03-13 05:27:10
Last Modified: 2024-03-13 05:27:28